Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × sargramostim × Clear all

Sponsor

Conditions

Leukemia 22 Lymphoma 14 Leukemia, Myeloid, Acute 14 Myelodysplastic Syndromes 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Breast Neoplasms 11 Prostatic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Multiple Myeloma 9 Melanoma 9 Lymphoma, Follicular 9 Neuroblastoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Ovarian Neoplasms 7 Congenital Abnormalities 7 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Lymphoma, Mantle-Cell 4 Leukemia, Myeloid, Chronic-Phase 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Waldenstrom Macroglobulinemia 3 Osteosarcoma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Valganciclovir 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 Imatinib Mesylate 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡